VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
AMTXAemetis, Inc.
$1.96$134M
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist

AMTX logoAemetis, Inc.(AMTX)Earnings, Financials & Key Ratios

AMTX•NASDAQ
Price updated Jun 19, 2026
SectorEnergyIndustryOil Refining & MarketingSub-IndustryRenewable and Alternative Fuels
AboutAemetis, Inc. operates as a renewable natural gas and renewable fuels company in North America and India. It operates through three segments: California Ethanol, Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the acquisition, development, and commercialization of negative carbon intensity products and technologies that replace traditional petroleum-based products. It sells biodiesel primarily to government oil marketing companies, transport companies, resellers, distributors, and private refiners through its own sales force and independent sales agents, as well as to brokers who resell the product to end-users. The company also produces and sells ethanol; and wet distillers grains, distillers corn oil, and condensed distillers solubles to dairies and feedlots as animal feed. In addition, it produces dairy biogas; produces and sells high-grade alcohol and various feed products, as well as hand sanitizers; and researches and develops conversion technologies using waste feedstocks to produce biofuels and biochemicals. The company was formerly known as AE Biofuels, Inc. and changed its name to Aemetis, Inc. in November 2011. Aemetis, Inc. was founded in 2005 and is headquartered in Cupertino, California.Show more
  • Revenue$208M-22.3%
  • EBITDA-$28M+13.7%
  • Net Income-$77M+12.0%
  • EPS (Diluted)-1.28+33.0%
  • Gross Margin-0.37%-70.4%
  • EBITDA Margin-13.29%-11.0%
  • Operating Margin-17.89%-18.5%
  • Net Margin-37.02%-13.2%

AMTX Key Insights

Aemetis, Inc. (AMTX) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

No significant strengths identified

✗Weaknesses

  • ✗Profits declining 16.0% over 5 years
  • ✗Negative free cash flow
  • ✗Shares diluted 43.3% in last year
  • ✗Trading more than 30% below 52-week high

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Get notified when AMTX posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

AMTX Price & Volume

Aemetis, Inc. (AMTX) stock price & volume — 10-year historical chart

Loading chart...

AMTX Growth Metrics

Aemetis, Inc. (AMTX) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years3.56%
5 Years4.67%
3 Years-6.75%
TTM-11.99%

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM15.54%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM36.31%

Return on Capital

10 Years-208.92%
5 Years-403.11%
3 Years-652.24%
Last Year-1900.33%

AMTX Recent Earnings

Aemetis, Inc. (AMTX) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 3/12 qtrs (25%)●Beat Revenue 0/12 qtrs (0%)
Q2 2026Latest
May 7, 2026
Metric
Actual
Est
EPS
$0.33-22.2%
$0.27
Rev
$55M-18.1%
$67M
Q2 2026
Mar 12, 2026
Metric
Actual
Est
EPS
$0.24+11.1%
$0.27
Rev
$54M-9.5%
$59M
Q4 2025
Nov 6, 2025
Metric
Actual
Est
EPS
$0.37-48.0%
$0.25
Rev
$59M-17.9%
$72M
Q3 2025
Aug 7, 2025
Metric
Actual
Est
EPS
$0.41-17.1%
$0.35
Rev
$52M-41.6%
$89M
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestMay 7, 2026
$0.33vs $0.27-22.2%
$55Mvs $67M-18.1%
Q2 2026Mar 12, 2026
$0.24vs $0.27+11.1%
$54Mvs $59M-9.5%
Q4 2025Nov 6, 2025
$0.37vs $0.25-48.0%
$59Mvs $72M-17.9%
Q3 2025Aug 7, 2025
$0.41vs $0.35-17.1%
$52Mvs $89M-41.6%
Based on last 12 quarters of dataView full earnings history →

AMTX Peer Comparison

Aemetis, Inc. (AMTX) competitors in Renewable and Alternative Fuels — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
Institutional Holdings
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
GEVO logoGEVOGevo, Inc.Direct Competitor374.85M1.54-118.49%-19.38%-7.19%0.36
REX logoREXREX American Resources CorporationDirect Competitor1.44B43.8417.541.24%14.13%13.67%0.03
ALTO logoALTOAlto Ingredients, Inc.Direct Competitor388.01M5.0231.38-4.9%3.16%12.53%0.40
GPRE logoGPREGreen Plains Inc.Direct Competitor1.04B14.82-8.23-14.93%-0.79%-2.01%0.66
AVA logoAVAAvista CorporationDirect Competitor3.29B39.7616.711.34%10.75%7.65%1.25
BIOX logoBIOXBioceres Crop Solutions Corp.Product Competitor23.58M0.37-0.45-28.3%-82.77%-92.01%0.94
CLNE logoCLNEClean Energy Fuels Corp.Product Competitor409.62M1.86-1.842.56%-22.65%-17.17%0.18
LOOP logoLOOPLoop Industries, Inc.Product Competitor40.16M0.83-3.19-95.28%-23.93%

Compare AMTX vs Peers

Aemetis, Inc. (AMTX) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs GEVO

Most directly comparable listed peer for AMTX.

Scale Benchmark

vs BE

Larger-name benchmark to compare AMTX against a more recognizable public peer.

Peer Set

Compare Top 5

vs GEVO, REX, ALTO, GPRE

AMTX Income Statement

Aemetis, Inc. (AMTX) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Sales/Revenue
150.16M171.53M202M165.56M211.95M256.51M186.72M267.64M207.98M209.36M
Revenue Growth %
4.89%14.23%17.77%-18.04%28.02%21.03%-27.21%43.34%-22.29%-11.99%
Cost of Goods Sold
146.78M166.12M189.3M154.53M204.01M262.05M184.7M268.22M208.75M202.29M
COGS % of Revenue
97.75%96.85%93.71%93.34%96.25%102.16%98.92%100.22%100.37%-
Gross Profit
3.38M▲ 0%
5.41M▲ 60.1%
12.7M▲ 134.9%
11.03M▼ 13.2%
7.94M▼ 28.0%
-5.54M▼ 169.7%
2.02M▲ 136.4%
-580K▼ 128.8%
-768K▼ 32.4%
7.07M▲ 0%
Gross Margin %
2.25%3.15%6.29%6.66%3.75%-2.16%1.08%-0.22%-0.37%3.38%
Gross Profit Growth %
-70.9%60.15%134.93%-13.18%-27.99%-169.72%136.44%-128.76%-32.41%-
Operating Expenses
15.56M16.33M17.63M17.09M23.76M28.87M39.42M39.84M36.45M35.07M
OpEx % of Revenue
10.36%9.52%8.73%10.33%11.21%11.25%21.11%14.88%17.53%-
Selling, General & Admin
13.19M16.09M17.42M16.88M23.68M28.69M39.27M39.84M36.45M25.98M
SG&A % of Revenue
8.78%9.38%8.63%10.2%11.17%11.18%21.03%14.88%17.53%-
Research & Development
2.37M246K205K213K88K180K152K000
R&D % of Revenue
1.58%0.14%0.1%0.13%0.04%0.07%0.08%---
Other Operating Expenses
0000000001000K
Operating Income
-12.18M▲ 0%
-10.93M▲ 10.3%
-4.93M▲ 54.9%
-6.07M▼ 23.1%
-15.82M▼ 160.7%
-34.4M▼ 117.4%
-37.4M▼ 8.7%
-40.42M▼ 8.1%
-37.22M▲ 7.9%
-28M▲ 0%
Operating Margin %
-8.11%-6.37%-2.44%-3.67%-7.47%-13.41%-20.03%-15.1%-17.89%-13.37%
Operating Income Growth %
-1459.92%10.32%54.87%-23.1%-160.71%-117.38%-8.72%-8.06%7.91%-
EBITDA
-7.17M-6.21M138K-1.13M-10.33M-28.82M-30.4M-32.03M-27.64M-20.79M
EBITDA Margin %
-4.77%-3.62%0.07%-0.68%-4.87%-11.24%-16.28%-11.97%-13.29%-9.93%
EBITDA Growth %
-278.56%13.43%102.22%-917.39%-815.87%-178.97%-5.47%-5.37%13.71%44.66%
D&A (Non-Cash Add-back)
5.01M4.72M5.07M4.94M5.49M5.58M7M8.39M9.58M7.21M
EBIT
-17.86M-18.07M-10.33M-10.02M-27.14M-85.3M-41.85M-58.21M-37.22M-23.26M
Net Interest Income
-19.3M-25.73M-28.01M-31.02M-20.14M-21.41M-32.99M-40.16M-61.14M-66.11M
Interest Income
0000000000
Interest Expense
19.3M18.21M28.01M31.02M20.14M21.41M32.99M40.16M61.14M66.11M
Other Income/Expense
-19.58M-25.35M-33.41M-31.57M-31.45M-72.3M-62.76M-57.95M-58.53M-58.28M
Pretax Income
-31.76M▲ 0%
-36.28M▼ 14.2%
-38.35M▼ 5.7%
-37.63M▲ 1.9%
-47.27M▼ 25.6%
-106.7M▼ 125.7%
-100.16M▲ 6.1%
-98.37M▲ 1.8%
-95.75M▲ 2.7%
-86.28M▲ 0%
Pretax Margin %
-21.15%-21.15%-18.98%-22.73%-22.3%-41.6%-53.64%-36.75%-46.04%-41.21%
Income Tax
6K7K1.13M-976K-128K1.05M-53.74M-10.83M-18.75M-12.1M
Effective Tax Rate %
-0.02%-0.02%-2.95%2.59%0.27%-0.99%53.65%11.01%19.58%14.02%
Net Income
-30.3M▲ 0%
-33.02M▼ 9.0%
-35.72M▼ 8.2%
-36.66M▼ 2.6%
-47.15M▼ 28.6%
-107.76M▼ 128.6%
-46.42M▲ 56.9%
-87.54M▼ 88.6%
-77M▲ 12.0%
-74.19M▲ 0%
Net Margin %
-20.18%-19.25%-17.68%-22.14%-22.24%-42.01%-24.86%-32.71%-37.02%-35.43%
Net Income Growth %
-93.79%-8.96%-8.18%-2.64%-28.61%-128.56%56.92%-88.58%12.04%15.54%
Net Income (Continuing)
-31.77M-36.29M-39.48M-36.66M-47.15M-107.76M-46.42M-87.54M-77M-74.19M
Discontinued Operations
0000000000
Minority Interest
-1.47M-4.74M00000000
EPS (Diluted)
-1.53▲ 0%
-1.63▼ 6.5%
-1.75▼ 7.4%
-1.74▲ 0.6%
-1.54▲ 11.5%
-3.12▼ 102.6%
-1.22▲ 60.9%
-1.91▼ 56.6%
-1.28▲ 33.0%
-1.11▲ 0%
EPS Growth %
-93.67%-6.54%-7.36%0.57%11.49%-102.6%60.9%-56.56%32.98%36.31%
EPS (Basic)
-1.53-1.63-1.75-1.74-1.54-3.12-1.22-1.91-1.28-
Diluted Shares Outstanding
19.83M20.25M20.47M21.01M30.68M34.59M38.06M45.9M65.78M66.8M
Basic Shares Outstanding
19.8M20.25M20.41M21.01M30.61M34.54M38.06M45.9M65.78M66.8M
Dividend Payout Ratio
----------

AMTX Balance Sheet

Aemetis, Inc. (AMTX) balance sheet — assets, liabilities & shareholders' equity

MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Total Current Assets
11.46M10.31M12.58M8.68M20.69M18.14M36.4M44.7M26.87M34.69M
Cash & Short-Term Investments
428K1.19M656K592K7.75M4.31M2.67M898K4.89M4.8M
Cash Only
428K1.19M656K592K7.75M4.31M2.67M898K4.89M4.8M
Short-Term Investments
0000000000
Accounts Receivable
2.22M1.1M2.04M1.82M1.57M1.26M8.63M14.11M484K6.58M
Days Sales Outstanding
5.392.333.684.012.711.816.8819.240.854.98
Inventory
5.74M6.13M6.52M3.97M5.13M4.66M18.29M25.44M11.63M10.38M
Days Inventory Outstanding
14.2713.4712.579.379.176.4936.1534.6220.3317.66
Other Current Assets
643K956K2.57M1.55M644K3.65M3.46M2.41M9.87M12.92M
Total Non-Current Assets
82.87M81.51M87.32M116.46M140.14M188.98M207.01M214.61M232.97M235.64M
Property, Plant & Equipment
78.84M78.49M84.78M112.77M137.56M167.45M181.73M186.2M219.72M222.74M
Fixed Asset Turnover
1.90x2.19x2.38x1.47x1.54x1.53x1.03x1.44x0.95x0.99x
Goodwill
0000000000
Intangible Assets
0000000000
Long-Term Investments
0000000000
Other Non-Current Assets
4.03M3.02M2.54M3.69M2.58M21.52M25.27M28.41M13.25M12.9M
Total Assets
94.33M▲ 0%
91.82M▼ 2.7%
99.9M▲ 8.8%
125.14M▲ 25.3%
160.83M▲ 28.5%
207.11M▲ 28.8%
243.41M▲ 17.5%
259.3M▲ 6.5%
259.84M▲ 0.2%
270.33M▲ 0%
Asset Turnover
1.59x1.87x2.02x1.32x1.32x1.24x0.77x1.03x0.80x0.83x
Asset Growth %
21.23%-2.66%8.79%25.27%28.52%28.78%17.52%6.53%0.21%12.54%
Total Current Liabilities
36.02M42.58M57.82M102.23M65.33M88.28M84.39M143.97M371.26M396.25M
Accounts Payable
10.46M13.5M15.97M20.74M16.41M26.17M32.13M33.14M23.42M23.72M
Days Payables Outstanding
2629.6630.7948.9829.3736.4563.545.140.9544.63
Short-Term Debt
18.57M20.35M22.74M59.52M22.78M49.22M37.03M90.53M317.87M342.63M
Deferred Revenue (Current)
6.99M8.73M00000000
Other Current Liabilities
3.31M5.4M8.44M9.79M12.85M12.56M14.82M20.3M29.97M29.9M
Current Ratio
0.32x0.24x0.22x0.08x0.32x0.21x0.43x0.31x0.07x0.09x
Quick Ratio
0.16x0.10x0.10x0.05x0.24x0.15x0.21x0.13x0.04x0.06x
Cash Conversion Cycle
-6.34-13.86-14.54-35.6-17.49-28.16-10.488.76-19.77-21.99
Total Non-Current Liabilities
136.71M154.82M196.45M207.65M215.74M320.69M375.99M379.26M195.41M195.22M
Long-Term Debt
138.16M164.82M179.69M170.1M165.99M197.02M257.69M247.53M00
Capital Lease Obligations
00200K2.58M2.32M2.19M1.78M000
Deferred Tax Liabilities
0000000000
Other Non-Current Liabilities
15K016.56M34.97M47.43M121.48M116.52M131.74M195.41M195.22M
Total Liabilities
172.72M197.4M254.27M309.88M281.07M408.97M460.38M523.23M566.67M591.47M
Total Debt
15.63M17.3M203M232.51M191.34M248.77M296.91M338.06M317.87M342.63M
Net Debt
15.2M16.11M202.35M231.92M183.59M244.45M294.24M337.16M312.98M337.83M
Debt / Equity
----------1.07x
Debt / EBITDA
--1471.03x-------16.48x
Net Debt / EBITDA
--1466.28x-------16.25x
Interest Coverage
-0.93x-0.99x-0.37x-0.32x-1.35x-3.98x-1.27x-1.45x-0.61x-0.35x
Total Equity
-79.86M▲ 0%
-105.58M▼ 32.2%
-154.37M▼ 46.2%
-184.74M▼ 19.7%
-120.24M▲ 34.9%
-201.85M▼ 67.9%
-216.98M▼ 7.5%
-263.93M▼ 21.6%
-306.83M▼ 16.3%
-321.14M▲ 0%
Equity Growth %
-60.32%-32.21%-46.21%-19.67%34.92%-67.88%-7.49%-21.64%-16.26%-64.6%
Book Value per Share
-4.03-5.21-7.54-8.79-3.92-5.84-5.70-5.75-4.66-4.81
Total Shareholders' Equity
-78.39M-100.84M-154.37M-184.74M-120.24M-201.85M-216.98M-263.93M-306.83M-321.14M
Common Stock
20K20K21K23K33K36K41K51K66K0
Retained Earnings
-160.19M-193.2M-237.42M-274.08M-321.23M-428.99M-475.4M-562.94M-639.94M-661.66M
Treasury Stock
0000000000
Accumulated OCI
-2.9M-3.58M-3.83M-4.11M-4.35M-5.45M-5.67M-6.37M-7.36M0
Minority Interest
-1.47M-4.74M00000000

AMTX Cash Flow Statement

Aemetis, Inc. (AMTX) cash flow — operating, investing & free cash flow history

MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Cash from Operations
-8.69M-5.51M-2.03M2.48M-20.65M-22.87M13.82M-32.93M3.26M3.1M
Operating CF Margin %
-5.79%-3.21%-1.01%1.5%-9.74%-8.91%7.4%-12.3%1.57%-
Operating CF Growth %
-2441.78%36.63%63.06%221.93%-932.54%-10.75%160.46%-338.18%109.91%194.88%
Net Income
-31.77M-36.29M-39.48M-36.66M-47.15M-107.76M-46.42M-87.54M-77M-74.19M
Depreciation & Amortization
5.01M4.72M4.48M4.94M5.49M5.58M7M8.39M9.63M9.68M
Stock-Based Compensation
1.1M836K694K995K3.93M6.41M7.66M8.31M5.77M3.56M
Deferred Taxes
5.4M874K1.12M-984K0832K-750K000
Other Non-Cash Items
118K7.59M6.92M9.33M11.69M66.02M32.25M22.7M14.55M28.78M
Working Capital Changes
11.45M16.77M24.22M24.85M5.39M6.05M14.08M15.21M50.32M35.26M
Change in Receivables
-1.01M1.08M-963K-1.09M94K294K-7.42M-5.55M13.6M12.85M
Change in Inventory
-2.37M-721K-491K2.39M-2.21M360K-13.84M-7.77M13.12M10.61M
Change in Payables
2.58M2.21M1M1.4M-5.2M2.18M13.73M-1.29M-7.53M-6.88M
Cash from Investing
-1.12M-4.07M-8.58M-17.31M-22.89M-31.31M-23.69M-14.15M-25.59M-23.77M
Capital Expenditures
-1.12M-4.07M-8.58M-19.34M-26.65M-39.16M-33.12M-20.25M-26M-24.18M
CapEx % of Revenue
0.74%2.38%4.25%11.68%12.57%15.27%17.74%7.57%12.5%11.55%
Acquisitions
000000000822K
Investments
----------
Other Investing
0002.03M3.76M7.85M9.43M6.11M411K-411K
Cash from Financing
8.38M10.39M10.09M14.78M50.7M53.63M9.09M44.62M26.41M25.16M
Debt Issued (Net)
8.38M3.43M4.44M-4.29M-56.03M42.61M18.92M14.27M7.65M9.04M
Equity Issued (Net)
004.82M18.87M106.42M11.99M-8.28M31.75M28.33M23.2M
Dividends Paid
0000000000
Share Repurchases
451K000000000
Other Financing
06.96M834K193K311K-963K-1.55M-1.41M-9.58M-7.08M
Net Change in Cash
-1.06M▲ 0%
760K▲ 171.8%
-532K▼ 170.0%
-64K▲ 88.0%
7.16M▲ 11285.9%
-752K▼ 110.5%
-719K▲ 4.4%
-2.45M▼ 240.6%
4.05M▲ 265.6%
4.32M▲ 0%
Free Cash Flow
-9.8M▲ 0%
-9.58M▲ 2.3%
-10.61M▼ 10.8%
-16.86M▼ 58.9%
-47.3M▼ 180.5%
-62.02M▼ 31.1%
-19.29M▲ 68.9%
-53.18M▼ 175.6%
-22.74M▲ 57.2%
-21.07M▲ 0%
FCF Margin %
-6.53%-5.59%-5.25%-10.18%-22.32%-24.18%-10.33%-19.87%-10.93%-10.07%
FCF Growth %
-3700%2.28%-10.77%-58.88%-180.54%-31.13%68.89%-175.65%57.24%48.58%
FCF per Share
-0.49-0.47-0.52-0.80-1.54-1.79-0.51-1.16-0.35-0.32
FCF Conversion (FCF/Net Income)
0.29x0.17x0.06x-0.07x0.44x0.21x-0.30x0.38x-0.04x0.28x
Interest Paid
3.09M5.59M2.48M1.32M5.68M19.52M9.81M9.22M01.42M
Taxes Paid
6K6K8K8K7K10K20K1.81M00

AMTX Key Ratios

Aemetis, Inc. (AMTX) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric201720182019202020212022202320242025TTM
Return on Equity (ROE)
---------24.28%
Return on Invested Capital (ROIC)
---7.71%-9.57%-21.48%-48.7%-46.8%-40.28%-70.33%-160.14%
Gross Margin
2.25%3.15%6.29%6.66%3.75%-2.16%1.08%-0.22%-0.37%3.38%
Net Margin
-20.18%-19.25%-17.68%-22.14%-22.24%-42.01%-24.86%-32.71%-37.02%-35.43%
Debt / Equity
----------1.07x
Interest Coverage
-0.93x-0.99x-0.37x-0.32x-1.35x-3.98x-1.27x-1.45x-0.61x-0.35x
FCF Conversion
0.29x0.17x0.06x-0.07x0.44x0.21x-0.30x0.38x-0.04x0.28x
Revenue Growth
4.89%14.23%17.77%-18.04%28.02%21.03%-27.21%43.34%-22.29%-11.99%
Related:AMTX Dividend History·AMTX Revenue History·AMTX Price History·AMTX P/E History·AMTX Financial Ratios·AMTX Institutional Holders

AMTX SEC Filings & Documents

Aemetis, Inc. (AMTX) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

May 7, 2026·SEC

Material company update

Mar 16, 2026·SEC

Material company update

Mar 12, 2026·SEC

10-K Annual Reports

3
FY 2026

Mar 16, 2026·SEC

FY 2025

Mar 14, 2025·SEC

FY 2024

Mar 29, 2024·SEC

10-Q Quarterly Reports

6
FY 2026

May 7, 2026·SEC

FY 2025

Nov 7, 2025·SEC

FY 2025

Aug 7, 2025·SEC

AMTX Frequently Asked Questions

Aemetis, Inc. (AMTX) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Aemetis, Inc. (AMTX) reported $209.4M in revenue for fiscal year 2025.

Aemetis, Inc. (AMTX) saw revenue decline by 22.3% over the past year.

Aemetis, Inc. (AMTX) reported a net loss of $74.2M for fiscal year 2025.

Dividend & Returns

Aemetis, Inc. (AMTX) had negative free cash flow of $21.1M in fiscal year 2025, likely due to heavy capital investments.

What if you invested $1,000 in AMTX back in 2004?

Total return calculator · dividends reinvested · 22+ years of data

See returns →

How much would $100/month in AMTX be worth today?

Dollar cost averaging calculator · DCA vs lump sum

Calculate →